AstraZeneca
benefitting from broad based diverse source of revenue strong commercial performance and financial execution in broad based diverse source of revenue reiterating guidance core to increase by a high single digit to low double digit | AstraZeneca
Company
Deck Type
Deck date
July 2023
Slide
5 of 44
Similar slides by AstraZeneca
Results
November 2023
Results
November 2023
Results
July 2023
Results
February 2023
Related slides by other companies
Results
August 2023
SPAC
September 2021
SPAC
July 2019
Results
July 2023
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io